Figure 4 — The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy

Research Paper|Volume 15, Issue 19|pp. 10305–10329

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy

Back to articleFigure 4(4 of 10)

100%

Figure 4.Assessment of risk models. (A) Kaplan-Meier survival analysis of signatures in the TCGA and five GEO datasets. (B) Observation of the distribution of samples in high- and low-risk groups using PCA analysis.